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Reproducibility of retinal thickness measurements in healthy
subjects using spectralis optical coherence tomography
Abstract
PURPOSE: To test the reproducibility of retinal thickness measurements in healthy volunteers of a new
Frequency-domain optical coherence tomography (OCT) device (Spectralis OCT; Heidelberg
Engineering, Heidelberg, Germany). DESIGN: Prospective, observational study. METHODS: Forty-one
eyes of 41 healthy subjects were included into the study. Intraobserver reproducibility was tested with
20 x 15 degree raster scans consisting of 37 high-resolution line scans that were repeated three times by
one examiner (M.N.M.). Mean retinal thickness was calculated for nine areas corresponding to the Early
Treatment Diabetic Retinopathy Study (ETDRS) areas. Coefficients of variation (COV) were calculated.
RESULTS: Retinal thickness measurements were highly reproducible for all ETDRS areas. Mean total
retinal thickness was 342 +/- 15 microm. Mean foveal thickness was 286 +/- 17 microm. COVs ranged
from 0.38% to 0.86%. Lowest COV was found for the temporal outer ETDRS area (area 7; COV,
0.38%). Highest COV was found for the temporal inner ETDRS area (area 3; COV, 0.86%). Mean
difference between measurement 1 and 2, measurement 1 and 3, and measurement 2 and 3 for all
ETDRS areas was 1.01 microm, 0.98 microm, and 0.99 microm, respectively. CONCLUSION:
Spectralis OCT retinal thickness measurements in healthy volunteers showed excellent intraobserver
reproducibility with virtually identical results between retinal thickness measurements performed by one
operator.
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Introduction: 
Evaluation of retinal thickness has become fundamental for diagnosing 
and managing various retinal diseases such as diabetic maculopathy, retinal 
dystrophies, central serous retinopathy, retinal vein occlusions, and age related 
macular degeneration. In the past, retinal edema or atrophy could only be 
assessed subjectively by funduscopy. This method requires clinical experience 
and offers only qualitative data. In addition, exact comparisons over time are 
almost impossible. Successively, other techniques such as stereoscopic color 
photographs of the macular became available, and facilitated comparisons over 
time. The confocal scanning laser ophthalmoscope was one of the first 
instruments that allowed objective and quantitative evaluation of retinal 
thickness.1 
Optical coherence tomography (OCT) was introduced 1991 as a non-
invasive, cross sectional imaging technique.2 In 1995 time-domain OCT was 
used first for imaging macular diseases.3,4 Since than, OCT has become widely 
accepted for retinal thickness measurements in various retinal diseases.  
Time-domain OCT uses a scanning interferometer and an 820-nm infrared 
light source which is split into two separate beams. One beam is scanning a 
tissue being analyzed, and the other one acts as a reference beam which is 
reflected by a reference mirror. The distance of the reference mirror can be 
adjusted and therefore the time it takes for the reference beam to reach the 
sensor can be changed. By comparing the two light beams, time-domain OCT 
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measures the optical backscattering of light to generate a cross sectional image 
of the tested tissue. 
Recently, improvements in OCT technology have been introduced.5-6 
Frequency-Domain OCT (FD-OCT) provides increased axial resolution and 
scanning speed by recording the interferometric information using a frequency 
domain spectrometric method instead of adjusting the position of a reference 
mirror. Resolution is up to five times higher and imaging speed is up to 100 times 
faster than in conventional time-domain OCT. 7-8 Recent studies have shown that 
FD-OCT is capable of imaging retinal pathologies in great detail.9-12 
 Conventional time-domain OCT (Stratus OCT) provides six intersecting 
radial lines for macular scanning to measure retinal thickness. Due to the higher 
scanning speed, FD-OCT can perform high-density raster-scans to measure total 
retinal thickness or retinal nerve fiber layer thickness with less need of data 
interpolation. Recently, Spectralis™ OCT (Heidelberg Engineering, Heidelberg, 
Germany) has been introduced for retinal imaging.13 The instrument features an 
eye tracking device that corrects for eye movement during the scanning process. 
Implementation of eye tracking should lead to highly reproducible retinal 
thickness measurements. Hence, the goal of this study was to test intraobserver 
reproducibility of retinal thickness measurements performed with the Spectralis™ 
OCT in healthy subjects.  
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Methods: 
 Forty-one eyes of 41 healthy subjects (mean age 28 ± 5 years, 24 female) 
were included into the study. Exclusion criteria were the presence of a refractive 
error of > ±5 diopters, astigmatism of > 2 diopters, media opacifications, a history 
of ocular trauma or ocular diseases affecting the cornea, lens, retina, or optic 
nerve. The intraocular pressure of the study eye had to be between 11 and 21 
mmHg. All subjects received a slitlamp exam, fundus biomicroscopy and indirect 
ophthalmoscopy prior to inclusion. In addition, the intraocular pressure was 
measured. All subjects gave informed written consent to participate in the study 
which adhered to the tenets of the Declaration of Helsinki. Study eyes were 
chosen randomly. Twenty-one right eyes were included. Left eyes were treated 
as mirror images of right eyes for analysis. All OCT scans were performed with 
the Spectralis™ OCT which provides up to 40000 A-scans/sec with a depth 
resolution of 7 µm in tissue and a transversal resolution of 14 µm by using a 
superluminescence diode with 870 nm bandwidth. OCT retinal thickness scans 
were performed 3 times by one operator (MM) within one session. Between 
measurements the subject had to lean back. Position of the head-rest and OCT 
correction for spherical errors was re-adjusted between each measurement. The 
instrument combines OCT technology with a confocal Scanning Laser 
Ophthalmoscope which provides a reference fundus image. Each OCT B-scan 
will be registered and locked to a reference image. OCT software can identify 
previous scan locations and “guide” the OCT laser to scan the same location 
again. For this purpose, the first complete volume scan was set as a reference 
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scan. The Spectralis™ OCT has a follow up function to ensure that the same 
scanning location is identified on following visits by the tracking program. In 
addition, eye tracking and the high scanning speed is supposed to reduce 
moving artifacts. For OCT scanning the Spectralis™ OCT provides an ART 
function (Automatic Real Time) for increased image quality. With ART activated, 
multiple frames (B-scans) of the same scanning location are performed during 
the scanning process and images are averaged for noise reduction. The number 
of frames can be adjusted. In this study the ART function was turned on and 3 
frames were acquired for each B-scan location to reduce noise and to improve 
image quality. Scans were acquired in the high-resolution acquisition mode. 
 For retinal thickness measurements 20x15° raster scans were performed 
consisting of 37 high-resolution line scans. An internal fixation light was used to 
center of the scanning area on the fovea. Scans with low quality and a failing 
retinal thickness algorithm were excluded and measurements were repeated until 
good quality was achieved. In addition, scans with blinks during the scanning 
process were excluded and repeated.  
 Spectralis™ OCT provides a software algorithm for retinal thickness 
measurements. Each scan was separately analyzed by using the retinal 
thickness algorithm to generate retinal thickness values in µm. 
Retinal thickness values were calculated for 9 areas corresponding to the 
ETDRS (Early Treatment Diabetic Retinopathy Study) areas.14 The ETDRS plot 
consists of 3 concentric rings with diameters of 1, 2, and 3 mm. The two outer 
rings are divided into quadrants by two intersecting lines. Examples of a retinal 
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thickness measurement are shown in Figure 1. More common for retinal 
thickness measurements is a 1, 3, and 6 mm ETDRS plot, known from Stratus 
OCT. However, at the time of data acquisition, the 1, 3, 6 mm pattern was not 
available in the Spectralis™ OCT software. The ETDRS grid was positioned 
automatically by the Spectralis™ OCT software and retinal thickness values were 
extracted as captured. No manual adjustments of the grid were performed by the 
operator.  Coefficients of variation (COV) were calculated by calculating mean 
retinal thickness values and standard deviations (SD) out of the 3 measurements 
taken for each ETDRS area and then dividing SD by mean retinal thickness 
values for each study subject. Differences in COV between ETDRS areas were 
analyzed by using paired student t-test. 
 
Results: 
 The table shows mean retinal thickness values, standard deviations, and 
COV values for the 9 ETDRS areas tested. Retinal thickness measurements 
were highly reproducible for all ETDRS areas. Mean total retinal thickness was 
342 ± 15 µm. Mean foveal thickness was 286 ± 17 µm. Mean difference between 
measurement 1 and 2, measurement 1 and 3, and measurement 2 and 3 for all 
ETDRS areas was 1.01 µm, 0.98 µm, and 0.99 µm, respectively. Mean COV was 
0.54 ± 0.13 %. Lowest COV was found for the temporal outer ETDRS area (area 
7; COV: 0.38%). Highest COV was found for the temporal inner ETDRS area 
(area 3; COV: 0.86%). COV of area 7 was significantly lower compared to area 1, 
2, 3, 5, 6, and 8 (p-values ranged from p<0.0017 to p<0.0275). Figure 2 shows 
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box plots of COV values for each ETDRS area tested. Seven OCT examinations 
had to be repeated due to bad scan quality, failing retinal segmentation 
algorithm, or blinks during the scanning process. 
 
Discussion: 
The latest commercially available generation of FD-OCT has several 
advantages compared to conventional time-domain OCT. High-speed imaging 
allows to increase the number of acquired B-scans to yield greater retinal 
coverage and high-definition 3d-images. Higher scan density leads to more 
detailed retinal thickness maps with less need of data interpolation. In this study 
37 B-scans were used to scan a 20x15° area centered on the fovea. The 
Spectralis™ OCT has the option to increase B-scan density further for even 
better retinal coverage. However, higher scan density leads to longer 
examination time. Therefore, 37 B-scans were chosen as a compromise between 
sufficient retinal coverage and acceptable examination duration. One has to point 
out that examination time is not the same as scanning speed. Scanning speed of 
the Spectralis™ OCT for a B-scan image is extremely fast performing up to 
40000 A-scans/sec. However, B-scans will only be performed if the eye tracking 
software recognizes the exact scanning position in the fundus image. Therefore, 
examination time will increase with poor fixation and eye movements. This is a 
major difference in the concept of image acquisition between Spectralis™ OCT 
and most other available OCT models which perform sweep scans. The concept 
of sweep scans is to scan a larger area (i.e. 6x6mm) in the shortest possible time 
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without correcting for eye movements. Other commercially available FD-OCT 
models are able to perform up to128 B-scan in a 6x6mm area in about 2 seconds 
using the sweep scan technique. This leads to excellent retinal coverage in a 
short examination time. However, eye movements during the scanning process 
will most likely cause image artifacts and decrease reproducibility of retinal 
thickness measurements.   
In addition to retinal coverage, single B-scan quality and scan resolution 
seems to be an important factor for reproducibility of retinal thickness 
measurements. Higher scan resolution of FD-OCT allows a more detailed 
differentiation of retinal layers. Spectralis™ OCT has the potential of imaging with 
an axial resolution of up to 7 µm. In addition, it performs multiple B-scans at the 
same scanning location during the scanning process to average images for noise 
reduction in order to increase image quality. Our results showed that 
intraobserver reproducibility of retinal thickness measurements was excellent for 
all ETDRS areas with a mean difference between measurements of about only 1 
µm. Further studies are needed to show if the concept of image acquisition with 
eye tracking is superior to the sweep scan technique of other FD-OCT models. 
Direct comparison of the different imaging concepts might help to answer the 
question if retinal coverage is more important than single scan resolution and 
precision in clinical routine. The excellent reproducibility of retinal thickness 
measurements with the Spectralis™ OCT can be due to different technical 
factors such as improved image resolution, imaging speed, scan coverage, or 
retinal segmentation algorithms. Most likely, improved reproducibility is due to the 
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eye tracking mechanism and a combination of the technical improvements 
discussed above. However, other factors such as performance of the operator 
have not been tested in this study and therefore the role of the operator 
experience on reproducibility is unknown. In addition, no comparison was made 
between Spectralis™ OCT and Stratus OCT, as being the gold standard for 
retinal thickness measurements. 
 Reproducibility of any diagnostic test is important for diagnostic precision. 
In particular, reproducibility of retinal thickness measurements is critical if the 
device is used to monitor progression of the disease and/or therapeutic 
interventions. One should be aware that high diagnostic precision is not similar to 
high diagnostic accuracy. From this study, one can not determine if the retinal 
thickness measured by OCT represents the actual retinal thickness in vivo. In 
fact, OCT retinal thickness measurements are highly dependent on retinal 
segmentation algorithms which can be different between OCT models.15 For 
example, mean foveal thickness was 286 µm measured with Spectralis™ OCT. 
These values are significantly higher compared to previous findings with Stratus 
OCT.15  The main difference between retinal segmentation algorithms is that 
Spectralis™ OCT includes the retinal pigment epithelium (RPE) when measuring 
retinal thickness, whereas Stratus OCT measures above the RPE at the inner/ 
outer photoreceptor junction which leads to significantly lower retinal thickness 
values. 
 Various data on OCT retinal thickness measurement reproducibility has 
been published previously. Bauman M et al. tested reproducibility of retinal 
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thickness measurements of a prototype instrument of the first generation OCT, 
showing that mean COVs ranged from 3.6% to 29.5% in the automated method. 
When manually adjusting the retinal thickness algorithm COVs ranged from 3.2% 
to 7.2%.16 Massin P et al. used the first commercially available OCT to test 
reproducibility of retinal thickness measurements in 9 ETDRS areas of 10 healthy 
eyes. Mean COVs ranged from 0.6% to 3.3%. Intraclass correlation coefficients 
(ICC) ranged from 0.89 to 0.99. In addition, reproducibility was tested in diabetic 
patients with macular edema. ICCs were always larger than 0.98 and the 
reproducibility was ±6% in these patients.17 Other studies also showed good 
reproducibility with overall coefficients of repeatability between 1% and 2% and 
an expected variation of less than 11 µm between measurements. 18, 19  
Other groups studied reproducibility of retinal thickness measurements by using 
the Stratus OCT3 device. Guerses-Oezden et al. found good reproducibility with 
a COV of 5.8% for the Fast Macular Scan (FMS) and a COV of 4.7% for the 
Radial Line Scan (RLS) in healthy subjects.20 Polito et al. tested reproducibility in 
healthy subjects and patients with diabetic macular edema. COVs ranged from 
1.68% to 6.63% in the healthy group and from 4.84% to 8.33% in the diabetic 
group.21 Paunescu et al. found ICCs for retinal thickness measurements in the 9 
ETDRS areas between 52% and 97% with the FMS protocol and ICCs between 
35% and 96% with the RLS protocol.22 
Direct comparison of reproducibility studies is not possible because 
experimental and statistical methods vary between studies. Reasons for study 
differences include parameters such as different measurement regions of 
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different retinal coverage, different study-groups with different retinal health, 
different OCT models and/or equipment settings (scan types), different operator 
experience and automated or manual analysis protocols. Nevertheless there is a 
clear consensus that OCT macular thickness measurements show satisfactory 
reproducibility and repeatability.  
Our study tested intraobserver reproducibility of retinal thickness 
measurements within one session in healthy subjects. One would expect only 
little between subject variance in a group of young healthy subjects. Caution 
should be used when applying these data on older subjects or patients with 
retinal diseases who are expected to have a greater between subject variance. 
Therefore, additional studies are needed testing reproducibility of retinal 
thickness measurements of the Spectralis™ OCT in patients with macular 
diseases.  In addition, further studies are needed to test intersession- and 
interobserver reproducibility of retinal thickness measurements before 
Spectralis™ OCT can be safely used as a tool for monitoring retinal thickness. 
Our data showed a significantly lower COV for area 7, which represents 
the temporal outer quadrant, compared to area 1, 2, 3, 5, 6, and 8. The reason 
for that is not clear, especially as areas 4 and 9 for which significance could not 
be shown are located inferior and nasal to the fovea. Knighton et al. found lower 
reproducibility nasally compared to other quadrants when measuring retinal 
nerve fiber layer thickness with OCT.23 Difference in the angle of incidence of the 
illuminating beam might have an influence on scan-image quality and therefore 
on the retinal segmentation algorithm.  However, from a clinical perspective 
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differences between measurements were only marginal even in area 3 with the 
highest COV. Mean differences of about 1 µm between measurements might not 
have any clinical relevance. 
In conclusion, retinal thickness measurements could successfully be 
performed in all ETDRS areas. Our results indicate excellent intraobserver 
reproducibility for retinal thickness measurements performed by the Spectralis™ 
OCT in healthy controls.  
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Figure legends: 
 
 
Figure 1: 
 
Example of a retinal thickness measurement with Spectralis™ OCT in a healthy 
control. Upper left: Scanning Laser Ophthalmoscope fundus image showing the 
ETDRS (Early Treatment Diabetic Retinopathy Study) plot centered on the fovea. 
ETDRS areas are numbered. Upper right: Corresponding retinal thickness plot. 
Values are given in µm. Middle right: The rectangle indicates the scanning area. 
36 B-line scans were performed. Bottom: B-line scan centered on the fovea. 
 
Figure 2: 
Box plots showing differences in coefficients of variation between ETDRS areas 
measured with Spectralis™ OCT . For better illustration the scale of the y-axis is 
adjusted. One data point for area 3 has been marked as being outside the scale. 
The actual value is given in the plot. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14 
Acknowledgements 
 
A. Funding/ Support: none 
B. Financial Disclosures: none 
C. Contributions to Authors: Design of the study (MM, SV; Conduct of 
the study (MM, DS); Collection and management of data (DS); 
Interpretation of data (MM, SV); Preparation of the manuscript (MM, 
SV); Approval of the final manuscript (MM, DS, SV) 
D. All subjects gave informed consent to participate in the study that 
was conducted in accordance with the Institutional Review Board of 
the University Hospital Zurich and the tenets of the Declaration of 
Helsinki. 
E. Other acknowledgments: none 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15 
References: 
 
1) Jean B, Frohn A, Thiel JH. Laser scanning in ophthalmology. Fortschr 
Ophthalmol. 1990;87:158-167 
2) Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. 
Science. 1991 Nov 22;254:1178-1181 
3) Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of 
the human retina. Arch Ophthalmol. 1995;113:325-332 
4) Puliafito Ca, Hee MR, Lin CP, et al. Imaging of macular diseases with 
optical coherence tomography. Ophthalmology. 1995;102:217-229 
5) Choma MA, Sarunic MV, Yang C, Izatt JA. Sensitivity advantage of swept 
source and Fourier domain optical coherence tomography. Opt Express. 
2003;11:2183-2189 
6) Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal 
imaging with high-speed ultrahigh-resolution optical coherence 
tomography. Ophthalmology. 2005;112:1734-1746 
7) Wojtkowski M, Srinivasan V, Ko T, Fujimoto JG, Kowalczyk A, Duker JS. 
Ultrahigh-resolution, high-speed, Fourier domain optical coherence 
tomography and methods for dispersion compensation. Opt Express. 
2004;12:2404-2422 
8) Wojtkowski M, Srinivasan V, Ko T, et al. High speed, ultrahigh resolution 
retinal imaging using spectral/Fourier domain OCT. Conf Lasers 
Electrooptics. 2005;3:2058-2060 
 16 
9) Srinivasan V, Wojtkowski M, Witkin AJ, et al. High-definition and 3-
dimensional imaging of macular pathologies with high-speed ultrahigh-
resolution optical coherence tomography. Ophthalmology. 2006;113:2054-
2065 
10) Alam S, Zawadzki RJ, Choi S, et al. Clinical application of rapid serial 
Fourier-Domain optical coherence tomography for macular imaging. 
Ophthalmology. 2006;113:1425-1431 
11) Schmid-Erfurth U, Leitgeb RA, Michels S, et al. Three-dimensional 
ultrahigh-resolution optical coherence tomography of macular diseases. 
Invest Ophthalmol Vis Sci. 2005;46:3393-3402 
12) Ahlers C, Geitzenauer W, Simader C, et al. New perspectives in 
diagnostics. High-resolution optical coherence tomography of age-related 
macular degeneration. Ophthalmologe. 2008 Mar;105(3):248-54  
13) Wolf-Schnurbusch UE, Enzmann V, Brinkmann CK, Wolf S. Morphological 
changes in patients with geographic atrophy assessed with a novel 
spectral OCT-SLO combination. Invest Ophthalmol Vis Sci. 2008 
Jul;49(7):3095-9 
14) Photocoagulation for diabetic macular edema. Early treatment diabetic 
retinopathy study report number 1. Early Treatment Diabetic Retinopathy 
Study research group. 1985;103:1796-1806 
15) Menke MN, Dabov S, Sturm V. Comparison of three different OCT models 
for total macular thickness measurements in healthy controls. 
Ophthalmologica 2008 in press 
 17 
16) Baumann M, Gentile RC, Liebmann JM, Ritch R. Reproducibility of retinal 
thickness measurements in normal eyes using optical coherence 
tomography. Ophthalmic Surg Lasers. 1998;29:280-285 
17) Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A. 
Reproducibility of retinal mapping using optical coherence tomography. 
Arch Ophthalmol. 2001;119:1135-1142 
18) Muscat S, Parks S, Kemp E, Keating D. Repeatability and reproducibility 
of macular thickness measurements with the Humphrey OCT system. 
Invest Ophthalmol Vis Sci. 2002;43:490-495 
19) Koozekanani D, Roberts C, Katz SE, Herderick EE. Intersession 
Repeatability of macular thickness measurements with the Humphrey 
2000 OCT. Invest Ophthalmol Vis Sci. 2000;41:1486-1491 
20) Guerses-Oezden R, Teng C, Vessani R, Zafar S, Liebmann JM, Ritch R. 
Macular and retinal nerve fiber layer thickness measurement 
reproducibility using optical coherence tomography (OCT3). J Glaucoma. 
2004;13:238-244 
21) Polito A, Del Borrello M, Isola M, Zemella N, Bandello F. Repeatability and 
reproducibility of Fast Macular Thickness mapping with Stratus optical 
coherence tomography. Arch Ophthalmol. 2005;123:1330-1337 
22) Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber 
thickness, macular thickness, and optic nerve head measurements using 
Stratus OCT. Invest Ophthalmol Vis Sci. 2004;45:1716-1724  
 18 
23) Knighton RW, Qian C. An optical model of the human retina nerve fiber 
layer: implications of directional reflectance for variability of clinical 
measurements. J Glaucoma. 2000;9:56-62 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19 
Figure 1 
 
 
 
 
 
 
 
 
 20 
Figure 2 
 
